1998
DOI: 10.1006/bbrc.1998.9054
|View full text |Cite
|
Sign up to set email alerts
|

Janus Kinase 2 (Jak2) Must Be Catalytically Active to Associate with the AT1Receptor in Response to Angiotensin II

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
11
0

Year Published

1999
1999
2004
2004

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 8 publications
1
11
0
Order By: Relevance
“…However, this motif is not conserved in any of the other GPCRs known to associate with Jaks, raising questions about the significance of this observation. Available evidence indicates that Jak2 must be catalytically active to associate with the Ang II AT 1 receptor and to recruit STATs to the receptor (2,4). A kinase-inactive form of Jak2 with a mutation in subdomain VIII fails to associate with the receptor and to activate STAT1 following Ang II stimulation (2).…”
mentioning
confidence: 99%
“…However, this motif is not conserved in any of the other GPCRs known to associate with Jaks, raising questions about the significance of this observation. Available evidence indicates that Jak2 must be catalytically active to associate with the Ang II AT 1 receptor and to recruit STATs to the receptor (2,4). A kinase-inactive form of Jak2 with a mutation in subdomain VIII fails to associate with the receptor and to activate STAT1 following Ang II stimulation (2).…”
mentioning
confidence: 99%
“…Although JAK2 seems to physically associate with the AT 1 receptor, 4 its binding does not directly lead to JAK2 activation. 6 In this regard, Simon et al 7 reported that JAK2 activation in vitro depends on the presence of reactive oxygen species (ROS). Because Ang II activates the generation of O 2 Ϫ anions, 8 we hypothesized that a ROSgenerating system is involved in Ang II-induced activation of the JAK/STAT cascade and, subsequently, in interleukin-6 (IL-6) synthesis.…”
mentioning
confidence: 99%
“…To determine this, quiescent VSMC were either pretreated with Me 2 SO (control), pretreated with the Jak2 kinase inhibitor AG-490 (25), or pretreated with the Src family kinase inhibitor PP1 (26). For this study, we used 100 M of the Jak inhibitor AG-490, the lowest dose that in our hands fully inhibits Jak2 in cultured cells (27). After inhibitor treatment, cells were then left untreated or stimulated with 10 Ϫ7 M angiotensin II for either 5 min ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…We have previously used this system to delineate other Jak2 tyrosine phosphorylation-dependent cellular events (27). Using this system, COS-7 cells were transfected to express empty vector, Jak2 WT, or Jak2 DN.…”
Section: Resultsmentioning
confidence: 99%